![Charles David Ogilvy Potter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Charles David Ogilvy Potter
Profile
Dr. Charles D.
Potter is a Director & Chief Business Officer at Glide Pharmaceutical Technologies Ltd.
He is on the Board of Directors at Glide Pharmaceutical Technologies Ltd.
Dr. Potter was previously employed as a Principal by Powderject Pharmaceuticals Plc.
He received his undergraduate degree from the University of Cambridge and a doctorate degree from the University of Cambridge.
Former positions of Charles David Ogilvy Potter
Companies | Position | End |
---|---|---|
Powderject Pharmaceuticals Plc
![]() Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Corporate Officer/Principal | - |
Glide Pharmaceutical Technologies Ltd.
![]() Glide Pharmaceutical Technologies Ltd. Pharmaceuticals: MajorHealth Technology Glide Pharmaceutical Technologies Ltd. developed and manufactured pharmaceutical products. The firm developed SDI, a solid dose injector system to improve compliance in patients self-administering long term therapy. Its pipeline of solid dose formulations includes octreotide, teriparatide, and anthrax and influenza vaccines. It also engaged in developing a non-invasive diagnostic technology that primarily focuses on prostate cancer, which aims to identify clinically significant disease based on a biochemical marker. The company was founded by Charles David Ogilvy Potter on 6th March, 2001 and was headquartered in Abingdon, the United Kingdom. | Founder | - |
Training of Charles David Ogilvy Potter
University of Cambridge | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Glide Pharmaceutical Technologies Ltd.
![]() Glide Pharmaceutical Technologies Ltd. Pharmaceuticals: MajorHealth Technology Glide Pharmaceutical Technologies Ltd. developed and manufactured pharmaceutical products. The firm developed SDI, a solid dose injector system to improve compliance in patients self-administering long term therapy. Its pipeline of solid dose formulations includes octreotide, teriparatide, and anthrax and influenza vaccines. It also engaged in developing a non-invasive diagnostic technology that primarily focuses on prostate cancer, which aims to identify clinically significant disease based on a biochemical marker. The company was founded by Charles David Ogilvy Potter on 6th March, 2001 and was headquartered in Abingdon, the United Kingdom. | Health Technology |
Powderject Pharmaceuticals Plc
![]() Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Health Technology |
- Stock Market
- Insiders
- Charles David Ogilvy Potter